SCP
ARLZ

Silverleafe Capital Partners’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Silverleafe Capital Partners’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-100,000
Closed -$35K – 68
2018
Q2 		$35K Buy
+100,000
New +$82K 0.02% 62

Other funds holding ARLZ

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM